Reducing Systemic Inflammation in People on Antiretroviral Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Reducing Systemic Inflammation in People on Antiretroviral Therapy — Stella

Recruiting

Back to Human Immunodeficiency Virus (HIV) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

CR CHUM, Montreal, Quebec

Key details

Phase

Safety & dosing

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre, Clinique du Quartier Latin

Enrollment target

~150 participants

Started

September 2025

Primary completion

October 2028

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov